Congress trades
Veracyte, Inc. (VCYT)
About Veracyte, Inc.
from the company's filings and listing- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Chief executive
- Marc Stapley
- Employees
- 755
- Listed since
- Oct 29, 2013
- Market value
- $3.5B
- Price to earnings
- 30.5
- Earnings per share
- $1.44
- Dividend yield
- -
Earnings
6 reported quarters · next on Nov 3, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q2 FY2026reported Jul 30, 2026 | $0.54 | $0.41 | $150.3M | $144.6M | EPS beatRevenue beat |
| Q1 FY2026reported May 5, 2026 | $0.52 | $0.34 | $139.1M | $130.4M | EPS beatRevenue beat |
| Q4 FY2025reported Feb 25, 2026 | $0.53 | $0.41 | $140.6M | $135.8M | EPS beatRevenue beat |
| Q3 FY2025reported Nov 4, 2025 | $0.51 | $0.32 | $131.9M | $125.0M | EPS beatRevenue beat |
| Q2 FY2025reported Aug 6, 2025 | $0.44 | $0.31 | $130.2M | $121.0M | EPS beatRevenue beat |
| Q1 FY2025reported May 7, 2025 | $0.31 | $0.12 | $114.5M | $111.3M | EPS beatRevenue beat |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.
Executive pay
as filed for 2025 · proxy filed Apr 22, 2026| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| Marc StapleyChief Executive Officer | $700K | $5.9M | $831K | $7.4M |
| John LeiteGlobal Chief Commercial Officer | $510K | $2.4M | $336K | $3.2M |
| Rebecca ChambersChief Financial Officer | $550K | $2.0M | $362K | $2.9M |
| Annie McGuireGeneral Counsel and Head of Market Access | $500K | $2.0M | $330K | $2.8M |
| Phillip FebboChief Scientific Officer and Chief Medical Officer | $561K | $1.6M | $369K | $2.5M |
The summary compensation table from the 2025 proxy statement, current executives only. Read the filing
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Change | Of company |
|---|---|---|---|---|
| Blackrock, Inc. | $792.1M | 13,486,437 | +2.4% | 16.93% |
| FMR LLC | $452.4M | 7,702,746 | -0.8% | 9.67% |
| Artisan Partners Limited Partnership | $325.3M | 5,538,404 | +0.8% | 6.95% |
| Vanguard Portfolio Management LLC | $277.0M | 4,716,191 | +6.1% | 5.92% |
| State Street Corp | $276.0M | 4,698,128 | -6.8% | 5.90% |
| Vanguard Capital Management LLC | $211.1M | 3,593,922 | +1.7% | 4.51% |
| Dimensional Fund Advisors LP | $166.0M | 2,826,524 | -1.9% | 3.55% |
| First Trust Advisors LP | $147.3M | 2,507,902 | +18.5% | 3.15% |
| ARK Investment Management LLC | $134.8M | 2,295,951 | -24.8% | 2.88% |
| Wellington Management Group LLP | $133.6M | 2,274,160 | -11.1% | 2.85% |
| Geode Capital Management, LLC | $123.6M | 2,104,000 | +7.5% | 2.64% |
| Goldman Sachs Group Inc | $96.5M | 1,642,911 | +28.7% | 2.06% |
A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.
GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.
Congress trades in VCYT
14 disclosures of 14 on record · median 30d of the 45 allowed| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Gilbert Ray Cisneros, Jr. | Stock | Purchase | $1,001 - $15,000 | +25.0%S&P +12.0% · vs S&P 500 +13.0% | Mar 3, 2026 | Apr 7, 2026 | 35d |
| Gilbert Ray Cisneros, Jr. | Stock | Sale | $1,001 - $15,000 | +3.7%S&P +11.6% · vs S&P 500 -7.9% | Nov 12, 2025 | Dec 15, 2025 | 33d |
| Gilbert Ray Cisneros, Jr. | Stock | Purchase | $1,001 - $15,000 | +64.6%S&P +26.5% · vs S&P 500 +38.1% | Jun 16, 2025 | Jul 10, 2025 | 24d |
| Josh GottheimerJoint | Stock | Purchase | $1,001 - $15,000 | +106.1%S&P +75.0% · vs S&P 500 +31.1% | Oct 16, 2023 | Nov 11, 2023 | 26d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | +75.1%S&P +71.5% · vs S&P 500 +3.6% | Sep 15, 2023 | Oct 15, 2023 | 30d |
| Daniel S. Goldman | Stock | Sale | $1,001 - $15,000 | +105.9%S&P +86.2% · vs S&P 500 +19.7% | Apr 10, 2023 | May 19, 2023 | 39d |
| Gilbert Ray Cisneros, Jr. | Stock | Sale | $1,001 - $15,000 | -23.0%S&P +107.5% · vs S&P 500 -130.5% | Dec 23, 2020 | Jan 11, 2021 | 19d |
| Gilbert Ray Cisneros, Jr. | Stock | Sale | $1,001 - $15,000 | -23.2%S&P +108.0% · vs S&P 500 -131.2% | Dec 10, 2020 | Jan 11, 2021 | 32d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | -27.3%S&P +106.0% · vs S&P 500 -133.3% | Dec 8, 2020 | Jan 7, 2021 | 30d |
| Gilbert Ray Cisneros, Jr. | Stock | Sale | $1,001 - $15,000 | +19.2%S&P +131.1% · vs S&P 500 -112.0% | Oct 29, 2020 | Nov 5, 2020 | 7d |
| Gilbert Ray Cisneros, Jr. | Stock | Purchase | $1,001 - $15,000 | +45.5%S&P +129.8% · vs S&P 500 -84.3% | Jan 17, 2020 | Feb 18, 2020 | 32d |
| Gilbert Ray Cisneros, Jr. | Stock | Purchase | $1,001 - $15,000 | +53.2%S&P +140.6% · vs S&P 500 -87.4% | Dec 12, 2019 | Jan 10, 2020 | 29d |
| Gilbert Ray Cisneros, Jr. | Stock | Purchase | $1,001 - $15,000 | +48.2%S&P +137.5% · vs S&P 500 -89.3% | Dec 24, 2019 | Jan 10, 2020 | 17d |
| Josh GottheimerJoint | Stock | Purchase | $1,001 - $15,000 | +50.3%S&P +142.4% · vs S&P 500 -92.0% | Dec 6, 2019 | Jan 6, 2020 | 31d |
Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 10, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.
Members of Congress reporting a position
2 members · estimate, as of Sep 10, 20262 members report a position (estimated). The largest estimated position is in the $15,001 - $50,000 band.
| Member | Party, chamber | Estimated position | Share of their portfolio |
|---|---|---|---|
| Gilbert Ray Cisneros, Jr. | Democrat · House | $15,001 - $50,000 | 0.1% |
| Josh Gottheimer | Democrat · House | $1,001 - $15,000 | <0.1% |
Estimate, as of Sep 10, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, moved with the stock's price since the trade. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.
Questions
Which members of Congress have traded VCYT?
Gilbert Ray Cisneros, Jr., Josh Gottheimer, Daniel S. Goldman disclosed VCYT transactions in the filings shown here.
Which members of Congress hold VCYT?
2 members of Congress report a position in VCYT in the estimate we hold as of Sep 10, 2026. The two largest estimated positions belong to Gilbert Ray Cisneros, Jr. and Josh Gottheimer. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.
How quickly are VCYT trades disclosed?
Congressional disclosures took a median of 30 days, against the 45 the STOCK Act allows.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Sep 10, 2026.